HIV Vaccination, is Breakthrough Underway?
After long defeats-almost no marked breakthrough in HIV vaccination campaign has been observed during the past two decades, and we still have not lost our faiths for the development of highly effective and low risk HIV vaccines. Many effective vaccines have been discovered and will certainly enter into the markets within the next 5 to 10 years. In order to promote HIV vaccine developments and clinical HIV therapeutic improvements, this perspective addresses the good and bad sides of currently available HIV vaccines, discusses many subjects of medical significance and finally provides up-to-date information in the field of HIV studies, in particular regarding vaccine developments and HIV pathogenesis..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Reviews on recent clinical trials - 11(2016), 2, Seite 145-151 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Da-Yong Lu [VerfasserIn] |
|---|
| Links: |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1978665679 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1978665679 | ||
| 003 | DE-627 | ||
| 005 | 20230512165152.0 | ||
| 007 | tu | ||
| 008 | 160719s2016 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a PQ20160719 |
| 035 | |a (DE-627)OLC1978665679 | ||
| 035 | |a (DE-599)GBVOLC1978665679 | ||
| 035 | |a (PRQ)b1491-dbfada6b4a4288bd0564b04d6af0498e865b3e0520a4a418cee7b3e3b282be8c0 | ||
| 035 | |a (KEY)0598973620160000011000200145hivvaccinationisbreakthroughunderway | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ZDB |
| 100 | 0 | |a Da-Yong Lu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a HIV Vaccination, is Breakthrough Underway? |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a After long defeats-almost no marked breakthrough in HIV vaccination campaign has been observed during the past two decades, and we still have not lost our faiths for the development of highly effective and low risk HIV vaccines. Many effective vaccines have been discovered and will certainly enter into the markets within the next 5 to 10 years. In order to promote HIV vaccine developments and clinical HIV therapeutic improvements, this perspective addresses the good and bad sides of currently available HIV vaccines, discusses many subjects of medical significance and finally provides up-to-date information in the field of HIV studies, in particular regarding vaccine developments and HIV pathogenesis. | ||
| 700 | 0 | |a Hong-Ying Wu |4 oth | |
| 700 | 0 | |a Ting-Ren Lu |4 oth | |
| 700 | 0 | |a Bin Xu |4 oth | |
| 700 | 0 | |a Jian Ding |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Reviews on recent clinical trials |d Saif Zone, Sharjah [u.a.] : Bentham, 2006 |g 11(2016), 2, Seite 145-151 |w (DE-627)518259552 |w (DE-600)2251879-4 |x 1574-8871 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2016 |g number:2 |g pages:145-151 |
| 856 | 4 | 2 | |u http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1574-8871&volume=11&issue=2&spage=145 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2016 |e 2 |h 145-151 | ||